Report cover image

Artificial Intelligence in IVD Market Growth, Size, Trends Analysis - By Application, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published Jan 03, 2025
Length 248 Pages
SKU # SPER19520444

Description

Artificial Intelligence in IVD Market Growth, Size, Trends Analysis - By Application, By Technology, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Artificial Intelligence in IVD Market Introduction and Overview

According to SPER market research, ‘Global Artificial Intelligence in IVD Market Size- By Application, By Technology, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the Global Artificial Intelligence in IVD Market is predicted to reach 2.62 billion by 2033 with a CAGR of 22.6%.

The application of machine learning and computational algorithms to the analysis and interpretation of diagnostic data is known as artificial intelligence (AI) in in-vitro diagnostics (IVD). This is done to enhance clinical decision-making, accuracy, and efficiency in laboratory testing and medical diagnostics. Diabetes, heart disease, and cancer are among the chronic illnesses that are becoming more prevalent globally. AI is being used more and more to enhance the effectiveness, accuracy, and customized treatment options for a range of illnesses.

The Covid-19 epidemic has highlighted the value of artificial intelligence (AI) in in vitro diagnostics, particularly in domains such as medical imaging and clinical decision support. AI technology have helped in the identification and management of Covid-19 patients, allowing for the quick analysis of chest X-rays and CT scans to detect lung abnormalities. AI has also aided the creation of predictive models and risk assessment tools to help healthcare providers manage the epidemic.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Application, By Technology, By End User

Regions covered

North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered

Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, Danaher Corporation (Beckman Coulter), Sysmex Corporation, BioMerieux, Shenzhen Mindray Bio-Medical Electronics Co, Cardinal Health, PerkinElmer.

Artificial Intelligence in IVD Market Segmentation:

By Application: Based on the Application, Global Artificial Intelligence in IVD Market is segmented as; Oncology, Infectious Disease, Cardiology, Other Applications.

By Technology: Based on the Technology, Global Artificial Intelligence in IVD Market is segmented as; Machine Learning, Deep Learning, Other Technologies.

By End User: Based on the End User, Global Artificial Intelligence in IVD Market is segmented as; Hospitals and Clinics, Diagnostic Laboratories, Other End Users.

By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

248 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Artificial Intelligence in IVD Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Artificial Intelligence in IVD Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Artificial Intelligence in IVD Market
7. Global Artificial Intelligence in IVD Market, By Application (USD Million) 2020-2033
7.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2020-2026
7.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Application, 2027-2033
7.3. Oncology
7.4. Infectious Disease
7.5. Cardiology
7.6. Other Applications
8. Global Artificial Intelligence in IVD Market, By Technology (USD Million) 2020-2033
8.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2020-2026
8.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By Technology, 2027-2033
8.3. Machine Learning
8.4. Deep Learning
8.5. Other Technologies
9. Global Artificial Intelligence in IVD Market, By End User (USD Million) 2020-2033
9.1. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Artificial Intelligence in IVD Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals and Clinics
9.4. Diagnostic Laboratories
9.5. Other End Users
10. Global Artificial Intelligence in IVD Market Forecast, 2020-2033 (USD Million)
10.1. Global Artificial Intelligence in IVD Market Size and Market Share
11. Global Artificial Intelligence in IVD Market, By Region, 2020-2033 (USD Million)
11.1. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2020-2026)
11.2. Global Artificial Intelligence in IVD Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Abbott
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. F. Hoffmann-La Roche Ltd
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Siemens Healthineers AG
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Thermo Fisher Scientific Inc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Danaher Corporation
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Sysmex Corporation
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. BioMerieux
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Shenzhen Mindray Bio-Medical Electronics Co
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Cardinal Health
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. PerkinElmer
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us